Your Article Summary
Mirabilis Raises $4 Million to Commercialize Non-Invasive Treatment of Uterine Fibroids
Corporate News Releases - The Healthcare Sales & Marketing Network, 08/30/06
Mirabilis Medica, Inc., a privately-held medical device company, announced the initial closing of a $4 million Series A financing that will be used to complete development, testing and introduction of its image-guided High Intensity Focused Ultrasound (HIFU) system for treatment of gynecological diseases. The financing was co-led by Charter Life Sciences of Palo Alto and vSpring Capital of Salt Lake City
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Generic drugs dominate market, look to expand into biologics
Formulary , 12/16/09
Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/15/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/15/09

See Latest Articles